Claims:We Claim:

1. A mobile medical vehicle 100 for detecting and preventing coronavirus, the mobile medical vehicle 100 comprising:

a mobile medical vehicle body 102 having a driving section 104 and a testing section 106;

a plurality of test sample collecting units 108 arranged within the testing section 106, the plurality of test sample collecting units 108 is movable from inside the testing section 106 to outside the testing section 106 and vice versa;

a plurality of testing units arranged within the testing section 106, the plurality of testing units tests the test samples received via the plurality of test sample collecting units 108;

a plurality of vaccine injecting units 112 arranged within the testing section 106, the plurality of vaccine injecting units 112 is configured to inject vaccine to a patient by ejecting out from inside the testing section 106;

a solar panel mounted on the mobile medical vehicle body 102, the solar panel is adapted to collect the solar energy; and

an ultraviolet rays source 122 mounted on the mobile medical vehicle body 102, the ultraviolet rays source 122 is coupled to the solar panel and is configured to emit ultraviolet rays in an area around the mobile medical vehicle body 102.

2. The mobile medical vehicle 100 as claimed in claim 1, wherein the test sample collecting unit 108 is a tray.

3. The mobile medical vehicle 100 as claimed in claim 1, wherein the test sample is at least one of a blood sample or a nasopharyngeal sample of the patient.

4. The mobile medical vehicle 100 as claimed in claim 1, wherein the testing unit includes a blood sample testing unit and a nasopharyngeal sample testing unit.

5. The mobile medical vehicle 100 as claimed in claim 1, wherein the nasopharyngeal sample is tested via Reverse transcriptase Polymerase chain reaction.

6. The mobile medical vehicle 100 as claimed in claim 1, wherein the mobile medical vehicle 100 comprising a camera mounted on the mobile medical vehicle body 102.

7. The mobile medical vehicle 100 as claimed in claim 1, wherein the mobile medical vehicle 100 comprising a shoulder stability arrangement 120 to hold and restrict the movement of the shoulder.

8. The mobile medical vehicle 100 as claimed in claim 1, wherein the mobile medical device further comprising a biometric sensor 124 for providing access to the driving section 104 and the testing section 106.
, Description:TECHNICAL FIELD

The present invention generally relates to a mobile medical vehicle, and more particularly, the present invention relates to a mobile medical vehicle for detection and prevention of coronavirus.

BACKGROUND

Coronavirus disease (COVID-19) is an infectious disease caused by novel coronavirus. The increasing rate of coronavirus infection has caused a pandemic throughout the world. Awareness of symptoms early on and increased testing are the two keys to fighting the pandemic. Increased testing has also helped several countries to turn the tide over in the COVID battle. Anyone found to be suffering from the symptoms of coronavirus is requested to get the test done on priority. However, at present, COVID testing could only be done at specific hospitals and healthcare centres. Due to the exponential increase in the count of coronavirus cases, most of these hospitals and health centres are overburdened with the patients. This is leading to decrease in the testing rate. Further, people who want to get the test done are concerned about going to these hospitals and healthcare centres as they might get infection from there.

Further, in the conventional way of testing, the doctors and medical staff may have to come in contact with the people getting the test done. In such cases, it is likely that the doctors and medical staff could also catch this virus. Although the doctors are taking a lot of precautions by wearing masks, face shield, PPE kit etc., yet there have been cases where the doctors and medical staff got infected.

Therefore, in light of the discussion above, there is need for an invention for detecting and preventing coronavirus that can overcome the above limitations.

SUMMARY OF THE INVENTION

According to an exemplary embodiment of the invention, a mobile medical vehicle for detecting and preventing coronavirus is disclosed. The mobile medical vehicle includes a mobile medical vehicle body having a driving section and a testing section. The mobile medical vehicle further includes a plurality of test sample collecting units arranged within the testing section. The plurality of test sample collecting units is movable from inside the testing section to outside the testing section and vice versa. The mobile medical vehicle further includes a plurality of testing units arranged within the testing section. The plurality of testing units tests the test samples received via the plurality of test sample collecting units. The mobile medical vehicle further includes a plurality of vaccine injecting units arranged within the testing section. The vaccine injecting units is configured to inject vaccine to a patient by ejecting out from the testing section. The mobile medical vehicle further includes a solar panel mounted on the mobile medical vehicle body. The solar panel is adapted to collect the solar energy. The mobile medical vehicle further includes an ultraviolet rays source mounted on the mobile medical vehicle body. The ultraviolet rays source is coupled to the solar panel and is configured to emit ultraviolet rays in an area around the mobile vehicle body.

It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention, as claimed.

BRIEF DESCRIPTION OF THE ACCOMPANYING DRAWINGS

So that the manner in which the above recited features of the present invention can be understood in detail, a more particular description of the invention, briefly summarized above, may have been referred by embodiments, some of which are illustrated in the appended drawings. It is to be noted, however, that the appended drawings illustrate only typical embodiments of this invention and are therefore not to be considered limiting of its scope, for the invention may admit to other equally effective embodiments.

These and other features, benefits, and advantages of the present invention will become apparent by reference to the following figures, with like reference numbers referring to like structures across the views, wherein:

Fig. 1 illustrates a side view of a mobile medical vehicle for detecting and preventing coronavirus, in accordance with an exemplary embodiment of the present invention; and

Fig. 2 illustrates an internal view of a testing section of the mobile medical vehicle, in accordance with an exemplary embodiment of the present invention.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

While the present invention is described herein by way of example using embodiments and illustrative drawings, those skilled in the art will recognize that the invention is not limited to the embodiments of drawing or drawings described, and are not intended to represent the scale of the various components. Further, some components that may form a part of the invention may not be illustrated in certain figures, for ease of illustration, and such omissions do not limit the embodiments outlined in any way. It should be understood that the drawings and detailed description thereto are not intended to limit the invention to the particular form disclosed, but on the contrary, the invention is to cover all modifications, equivalents, and alternatives falling within the scope of the present invention as defined by the appended claim. As used throughout this description, the word "may" is used in a permissive sense (i.e. meaning having the potential to), rather than the mandatory sense, (i.e. meaning must). Further, the words "a" or "an" mean "at least one” and the word “plurality” means “one or more” unless otherwise mentioned. Furthermore, the terminology and phraseology used herein is solely used for descriptive purposes and should not be construed as limiting in scope. Language such as "including," "comprising," "having," "containing," or "involving," and variations thereof, is intended to be broad and encompass the subject matter listed thereafter, equivalents, and additional subject matter not recited, and is not intended to exclude other additives, components, integers or steps. Likewise, the term "comprising" is considered synonymous with the terms "including" or "containing" for applicable legal purposes. Any discussion of documents, acts, materials, devices, articles and the like is included in the specification solely for the purpose of providing a context for the present invention. It is not suggested or represented that any or all of these matters form part of the prior art base or were common general knowledge in the field relevant to the present invention.

In this disclosure, whenever a composition or an element or a group of elements is preceded with the transitional phrase “comprising”, it is understood that we also contemplate the same composition, element or group of elements with transitional phrases “consisting of”, “consisting”, “selected from the group of consisting of, “including”, or “is” preceding the recitation of the composition, element or group of elements and vice versa.

The present invention is described hereinafter by various embodiments with reference to the accompanying drawing, wherein reference numerals used in the accompanying drawing correspond to the like elements throughout the description. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiment set forth herein. Rather, the embodiment is provided so that this disclosure will be thorough and complete and will fully convey the scope of the invention to those skilled in the art. In the following detailed description, numeric values and ranges are provided for various aspects of the implementations described. These values and ranges are to be treated as examples only, and are not intended to limit the scope of the claims. In addition, a number of materials are identified as suitable for various facets of the implementations. These materials are to be treated as exemplary, and are not intended to limit the scope of the invention.

The present invention will now be described in detail with reference to the accompanying drawings. Referring now to Figure 1, a side view of a mobile medical vehicle 100 for detecting and preventing coronavirus is illustrated, in accordance with an exemplary embodiment of the present invention. For the purpose of explanation, coronavirus is a type of virus that causes respiratory illness. An example of the type of coronavirus includes SARS-COV-2 that causes a respiratory illness known as COVID-19. The mobile medical vehicle 100 (hereinafter referred to as ‘vehicle’) may be used to detect the people infected by the coronavirus. Further, the vehicle 100 may be used to inject vaccine to people thereby protecting them from getting infected by the coronavirus. Furthermore, the vehicle 100 may be capable of preventing the spread of coronavirus by eliminating the virus in required areas. It will be apparent to a person skilled in the art that as the vehicle 100 is mobile in nature, the vehicle 100 may be driven to different areas and the testing and prevention of coronavirus can be done in those areas. Moreover, the vehicle 100 may enable a plurality of tests to be conducted simultaneously on a plurality of people which will save a lot of time.

The mobile medical vehicle 100 for detecting and preventing coronavirus may include a mobile medical vehicle body 102. The mobile medical vehicle body 102 (hereinafter referred to as ‘vehicle body’) may be divided into a driving section 104 and a testing section 106. For the purpose of explanation, the front section of the vehicle body 102 may be the driving section 104 and the rear section of the vehicle body 102 may be the testing section 106. The driving section 104 and the testing section 106 may be separated from each other. According to an embodiment, the driving section 104 and the testing section 106 may be separated via an internal partition. According to another embodiment, the driving section 104 and the testing section 106 may be two separate bodies connected to each other via a connecting means. It will be apparent to a person skilled in the art that the driving section 104 and the testing section 106 may be separated for increasing the protection from the coronavirus.

The driving section 104 of the vehicle body 102 may include a driving seat from where a driver may ride the vehicle 100. In some embodiments, the driving section 104 may include two seats where one seat may be the driving seat and the other seat may be a passenger seat. The passenger seat may be usually occupied by a doctor or a medical staff. It should be noted that the driving system of the vehicle 100 may be similar to the ones known in the art. For example, the vehicle 100 may be a gear vehicle or a gearless vehicle. Further, the vehicle 100 may be at least one of a petrol vehicle, a diesel vehicle, a CNG vehicle, LPG vehicle, electric vehicle etc.

Referring now to Fig. 2, an internal view of the testing section 106 of the vehicle body 102 is illustrated in accordance with an exemplary embodiment of the present invention. The testing section 106 may be an enclosed section where the tests for detection of coronavirus may be conducted. In other words, the testing section 106 may include testing equipment to conduct test on samples received from patients. It should be noted that the term ‘patient’ here implies the people on whom the test is conducted and therefore the terms ‘patient’ and ‘people’ may be interchangeably used without limiting the scope of invention in any manner. The testing section 106 may have a door in order to enter inside the testing section 106. The door may be electrically communicated to a biometric sensor. In an embodiment, the biometric sensor may be a fingerprint sensor. In some embodiments, the finger print sensor may be provided on the door handle itself. The access inside the testing section 106 may be provided to selected medical staffs that are responsible for carrying out the testing on the test samples. The biometric sensor 124 may also be provided on the door handles of the driving section 104. It will be apparent to a person skilled in the art that the biometric sensor 124 will enhance the security of the vehicle 100 by providing an additional unlocking system for the vehicle 100.

The vehicle 100 for detecting and preventing coronavirus may include a plurality of test sample collecting units 108 arranged within the testing section 106. The test sample collecting units 108 may be disposed on an internal side surface of the testing section 106. The test sample collecting units 108 may be movable from inside the testing section 106 to outside the testing section 106 and vice versa. In other words, the test sample collecting units 108 may be movable from a retracted position to a deployed position and vice versa, where during the retracted position, the test sample collecting units 108 may be positioned inside the testing section 106, and during the deployed position, the test sample collecting units 108 may be positioned outside the testing section 106. In an embodiment, the movement of the test sample collecting units 108 from inside the testing section 106 to outside the testing section 106 may be a sliding movement. The sliding movement of the test sample collecting units 108 may be achieved via a hydraulic mechanism. However, other mechanisms for achieving the sliding movement of the test sample collecting units 108 may also be implemented in the vehicle 100. It should be further noted that the testing section 106 may have a plurality of slots 110 on the side surface of the testing section 106. Each of the test sample collecting units 108 may be movable outside the testing section 106 from inside the testing section 106 and vice versa via the respective slots 110. According to an embodiment, the test sample collecting unit 108 may be a tray. Further, each of the test sample collecting units 108 may include compartments where test samples of a patient may be placed. The test sample collecting units 108 may carry the test samples from outside the testing section 106 to inside the testing section 106. Therefore the medical staff responsible for conducting test of the test sample need not come in contact with the patient. The movement of each of the test sample collecting units 108 may be operated via the medical staff. It should be noted that the medical staff may be able to move each of the test sample collecting units 108 independently via a control system provided in the testing section 106 of the vehicle 100.

The vehicle 100 may further include a plurality of testing units arranged within the testing section 106 for conducting tests on the test samples received via the plurality of test sample collecting units 108. The testing units may be configured to perform testing of patients in three phases. In the first phase, a blood sample of a patient is tested. For testing the blood sample, the blood sample may be collected from the patient. In some scenarios, a medical staff may be available outside of the vehicle 100 for collecting blood sample from patients. The blood sample may be collected from the patient using a blood testing kit. Once the blood sample is collected, it is placed in the assigned test sample collecting unit 108 positioned outside the testing section. The test sample collecting unit 108 then moves within the testing section 106 and is analysed for the presence of coronavirus. It will be apparent from the description that the plurality of test sample collecting units 108 and the plurality of testing units may enable plurality of tests to be conducted simultaneously.

In the second testing phase, a nasopharyngeal sample of the patient is tested. The nasopharyngeal sample of the patient is collected via a cotton swab. In certain scenarios, a medical staff may be available outside the vehicle 100 for collecting the nasopharyngeal sample. The nasopharyngeal sample is then placed in the test sample collecting unit 108 when positioned outside the testing section 106. The nasopharyngeal sample may be specifically placed in the compartment of the test sample collecting unit 108. In an embodiment, the nasopharyngeal sample may be placed in a plastic wrap provided in the test sample collecting unit 108. The test sample collecting unit 108 then moves within the testing section 106 and is tested for the presence of coronavirus. The testing on nasopharyngeal sample is performed via the testing unit. In an embodiment, the testing unit may be inbuilt into the testing section 106 of the vehicle 100. It will be apparent from the description that the plurality of test sample collecting units 108 and the plurality of testing units may enable plurality of tests to be conducted simultaneously.

In the third phase of testing, a nasopharyngeal sample of the patient is tested. The nasopharyngeal sample of the patient is collected via the cotton swab. Once collected, the nasopharyngeal sample is then placed in the test sample collecting unit 108 when positioned outside the testing section 106. The nasopharyngeal sample may be specifically placed in the compartment of the test sample collecting unit 108. The nasopharyngeal sample is tested via Reverse Transcriptase Polymerase Chain Reaction (RT PCR). During the RT PCR testing, the testing unit converts the Ribonucleic acid (RNA) to Deoxyribonucleic acid (DNA) of the sample and amplifies it. During the amplifying process, if any fluorescence is detected then the patient to whom the sample belongs is infected with coronavirus. It will be apparent from the description that the plurality of test sample collecting units 108 and the plurality of testing units may enable plurality of tests to be conducted simultaneously.

In some embodiments, only one of the three tests may be conducted on a patient to identify whether the patient is infected by coronavirus. In another embodiment, all the tests may be conducted to identify whether the patient is infected. It will be apparent to a person skilled from the description that the vehicle may enable tests to be conducted on a plurality of people simultaneously. In certain embodiments, the vehicle 100 may include a digital display board to display the names of the patients who are infected with coronavirus. In some embodiments, the vehicle 100 may include a speaker to announce the names of the patients who are tested positive.

The vehicle 100 for detecting and preventing coronavirus may further include a plurality of vaccine injecting units 112. The vaccine injecting units 112 may be arranged within the testing section 106 of the vehicle 100. The vaccine injecting units 112 may be configured to inject vaccine to patients outside the vehicle 100. In an embodiment, the vaccine may be a drug to protect people from getting infected by coronavirus. In another embodiment, the vaccine may be a drug to cure the people already infected by the coronavirus. For injecting the vaccine, the vaccine injecting units 112 may eject out of the testing section 106. The vaccine injecting units 112 may be arranged such that the vaccine injecting units 112 may slide out of the testing section 106 from inside the testing section 106, and back inside the testing section 106. Such an arrangement may enable the medical staff to inject vaccine to the patients without coming in contact with the patients. Each of the vaccine injecting unit 112 may eject out of the testing section 106 via an opening provided on the side surface of the testing section 106. According to an embodiment, the vehicle may include a plurality of openings 114 where each opening 114 may be dedicatedly provided for one vaccine injecting unit 106. The vaccine injecting units 112 may inject vaccine to the shoulder of the patients. Therefore the vaccine injecting units 112 may be positioned such that they align with the shoulder of the patients. In an embodiment, the vehicle 100 may include a plurality of sliding seats 116 for patients to sit for the process of getting injected. The sliding seats 116 may slide out of the side bottom portion of the vehicle 100 and slide back in when not in use. It will be apparent to a person skilled in the art that the vaccine injecting units 112 and the sliding seats 116 are arranged such that multiple patients can receive the vaccine simultaneously.

The vehicle 100 may further include a camera arranged on the vehicle body 102. The camera may also be integrated with a position sensor. The camera may be provided to view the position of the patient to whom vaccine is to be injected. The camera may communicate the video of the patient to a monitor 118 inside the testing section 106. The medical staff inside the testing section 106 may view the position of the patient via the monitor 118. In some cases, the medical staff inside the testing section 106 may guide the patient to move in order to position according to the vaccine injecting unit 112. Once the patient occupies the correct position, a shoulder stability arrangement 120 may hold and restrict the movement of the shoulder of the patient. When the shoulder stability arrangement 120 holds the shoulder in position, the vaccine injecting unit may 112 inject the vaccine in the patient. In an embodiment, the shoulder stability arrangement 120 may be a mechanical arm configured to hold the shoulder in position. The shoulder stability arrangement 120 may also be configured to wipe the shoulder portion where the vaccine is injected.

The vehicle 100 for detecting and preventing coronavirus may further include a solar panel. The solar panel may be mounted on the vehicle body 102. Specifically, the solar panel may be mounted on the roof of the vehicle body 102. In an embodiment, the vehicle 100 may include one solar panel. In another embodiment, the vehicle 100 may include multiple solar panels arranged on the roof of the vehicle body 100. In some embodiments, the alignment of the solar panel may be changeable in order to position the solar panel towards the direction of sun. It will be apparent to a person skilled in the art that the solar panel may collect solar energy. The vehicle may further 100 include an ultraviolet rays source 1222 mounted on the vehicle body 102. In an embodiment, the ultraviolet rays source 122 may be mounted on the side external side surface of the vehicle body 102. The ultraviolet rays source 122 may be coupled to the solar panel. The heat energy collected from the solar panel may be transferred to the ultraviolet rays source 122. The ultraviolet rays source 122 may be configured to emit ultraviolet rays in the desired area to eliminate the corona virus in that area. In some embodiments, the vehicle may include a plurality of ultraviolet rays sources to emit ultraviolet rays around the vehicle. It will be apparent to a person skilled in the art that the ultraviolet rays source 122 may be a device that emits ultraviolet rays.

Various modifications to these embodiments are apparent to those skilled in the art from the description and the accompanying drawings. The principles associated with the various embodiments described herein may be applied to other embodiments. Therefore, the description is not intended to be limited to the embodiments shown along with the accompanying drawings but is to be providing broadest scope of consistent with the principles and the novel and inventive features disclosed or suggested herein. Accordingly, the invention is anticipated to hold on to all other such alternatives, modifications, and variations that fall within the scope of the present invention and appended claims.